Skip to main content
Cardiac CareFor professionals6 min read

Sacomni 50 for Doctors, Pharmacists and Distributors

Sacomni 50: Sacubitril & Valsartan Tablets (24 mg + 26 mg)

Practical notes on Sacomni 50 for prescribers, pharmacists and distributors: Schedule H handling, counselling points at the counter, storage at the pharmacy and how to source stock from EMK Omni Pharma.

Dispensing and Schedule H handling

Sacomni 50 carries the standard Schedule H caution: not to be sold by retail without the prescription of a registered medical practitioner. Retail pharmacies should record the dispensing in the prescription register as required, retain the prescription details, and dispense only the prescribed strength.

Product particulars for verification at the counter:

  • Composition: Sacubitril 24 mg and Valsartan 26 mg as sodium salt complex, with approved excipients
  • Dosage form: film-coated tablet
  • Pack: 10 x 14 tablets
  • Category: Cardiac Care
  • Marketed by EMK Omni Pharma, Mysuru, Karnataka, manufactured at GMP-certified contract units

Because the brand number describes the combined strength, confirm against both the brand designation and the molecule strengths when the prescription is written one way and the stock is labelled the other.

Patient counselling checklist

A short structured conversation at the counter prevents most avoidable problems.

  • Ask about an ACE inhibitor. These must not be taken concurrently, and a washout gap applies when switching. Refer back to the prescriber if one appears on the patient's list.
  • Ask about prior angioedema with any cardiac or antihypertensive medicine.
  • Ask about pregnancy or plans to conceive. Reinforce the fetal toxicity warning and the instruction to discontinue as soon as pregnancy is detected.
  • Advise swallowing the tablet whole with water, with or without food, at consistent times.
  • Explain the missed dose principle: take it when remembered unless the next dose is near, and never double up.
  • Warn about symptomatic hypotension, advising slow rising from bed or chair, particularly in the first days.
  • Flag potassium. Discourage potassium-based salt substitutes and unsupervised potassium supplements.
  • Flag NSAIDs bought over the counter.
  • Reinforce monitoring: serum potassium, creatinine and blood pressure as scheduled by the prescriber.
  • Note the assay point: sacubitril raises BNP, so NT-proBNP is generally preferred for monitoring.

Storage at the pharmacy

The label specifies storage in a cool, dry and dark place below 25°C. In Indian retail conditions that usually means a shaded interior rack away from the shopfront glass, with adequate cooling or ventilation, and a thermometer that is actually read.

Practical measures worth reviewing:

  • Keep cartons in outer shippers until required and avoid stacking near external walls
  • Protect against monsoon humidity with a dry store area and periodic checks for damp cartons
  • Rotate stock by expiry, first expiry first out, and check dates during every stock audit
  • Quarantine strips that are wet, crushed, torn or discoloured, and do not dispense them
  • Maintain batch traceability so a query can be answered quickly

Advise patients to store the carton away from the bathroom and the kitchen stove, and out of reach of children.

Points worth reinforcing with patients

Three messages tend to need repetition at every visit.

First, adherence. Both molecules work by shifting hormonal balance, and that balance holds only with steady daily use. Patients who feel well often assume the treatment can be paused.

Second, self-adjustment. Switching between strengths, borrowing an old strip or splitting tablets is a recurring source of avoidable hypotension and hyperkalaemia. The two strengths in this family are easily confused on a prescription slip.

Third, intercurrent illness. Vomiting, loose motions, fever and heat-related dehydration are the usual triggers for a rise in creatinine or potassium. Patients should make contact early rather than waiting for the next scheduled visit.

Suspected adverse reactions can be reported by prescribers and pharmacists through the Pharmacovigilance Programme of India.

Availability through EMK Omni Pharma

Sacomni 50 is part of the Cardiac Care range marketed by EMK Omni Pharma, Mysuru, Karnataka. The sibling strength Sacomni 100 supplies Sacubitril 49 mg with Valsartan 51 mg, and the range also includes cardiac and diuretic combinations such as Toromni Plus 10/50 with Torsemide 10 mg and Spironolactone 50 mg.

Pharmacies, hospitals, clinics, stockists and distributors who wish to enquire about availability, pack details, product literature or distribution arrangements can use the contact page on the EMK Omni Pharma website, or reach the team on WhatsApp at +91 94487 74372. It helps to state the product name and strength, the pack configuration required and the intended territory.

This article is for general information only and is not a substitute for advice from a registered medical practitioner.

Frequently asked questions

What documentation is needed to dispense Sacomni 50?
A valid prescription from a registered medical practitioner, handled per Schedule H requirements, with the dispensing recorded as required by the pharmacy's standard practice.
A prescription reads Sacomni 50 but the patient also has an ACE inhibitor. What now?
Do not dispense the combination for concurrent use. Refer the patient back to the prescriber, since these must not be taken together and a washout gap applies when switching.
How should the pharmacy handle a strip that arrived damp?
Quarantine it, do not dispense it, and raise the batch details with your supplier. Moisture-affected blisters should be kept aside for return or disposal.
What is the pack configuration for Sacomni 50?
It is supplied as 10 x 14 film-coated tablets, each containing Sacubitril 24 mg and Valsartan 26 mg as a sodium salt complex.
Which laboratory monitoring should be reinforced at the counter?
Serum potassium, serum creatinine and blood pressure as scheduled by the prescriber. Where natriuretic peptide monitoring is planned, NT-proBNP is generally preferred over BNP.
How can a distributor enquire about the EMK Omni Pharma cardiac range?
Through the contact page on the EMK Omni Pharma website or on WhatsApp at +91 94487 74372, mentioning the product, strength, pack size and territory of interest.

Need Sacomni 50 for your pharmacy, hospital or clinic?

EMK Omni Pharma supplies through authorised channels across Karnataka. Send an enquiry and our team will respond during business hours.

Related guides

Medical Disclaimer

This product information is intended for general awareness only and should not be considered medical advice. Please consult a registered medical practitioner before using any prescription medicine.